Effectiveness of erythropoiesis on supervised intradialytic oral iron and vitamin C therapy is correlated with Kt/V and patient weight

Clinical Nephrology

Volumn 53, Issue 4, 2000, Pages 276-282

  Tovbin, D ^a,b   Markowitz, A ^a   Mostoslavsky, M ^a   Landver, R ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Erythropoiesis; Erythropoietin; Hematocrit weight; Transferrin saturation

Indexed keywords

ASCORBIC ACID; IRON;

ARTICLE; BODY WEIGHT; CLINICAL ARTICLE; ERYTHROPOIESIS; FOLLOW UP; HEMATOCRIT; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON THERAPY; PATIENT COMPLIANCE; PREDICTION;

ADMINISTRATION, ORAL; ANEMIA, IRON-DEFICIENCY; ASCORBIC ACID; BODY WEIGHT; ERYTHROPOIESIS; HUMANS; IRON; MIDDLE AGED; RENAL DIALYSIS;

EID: 0034087248     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Alkhunaizi AM, Chan L 1996 Secondary oxalosis: a cause of delayed recovery of renal function in the setting of acute renal failure. JASN 7: 2320-2326
2. Auch RD, Kahn RA 1980 Posttransfusion hepatitis-current perspectives. Ann Intern Med 92: 539-546
3. Beinker NK, Voigt MD, Arendse M, Smit J, Stander IA, Kirsch RE 1996 Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C. J Hepatol 25: 633-638
4. Fishbane S, Kowalski EA, Imbriano LJ, Maesaka JK 1996 The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol 7: 2654-2657
5. Fishbane S, Maeseka JK 1997 Iron management in endstage renal disease. Am J Kidney Dis 29: 319-333
6. Gastaldello K, Vereerstraeten A, Nzame-Nze T, Vanherweghem JL, Tielemans C 1995 Resistance to erythropoietin in iron-overloaded haemodialysis patients can be overcome by ascorbic acid administration. Nephrol Dial Transplant 10 (Suppl): 44-47
7. Goch J, Birgegard G, Danielson BG, Wikstrom B 1996 Iron absorption in patients with chronic uremia on maintenance hemodialysis and in healthy volunteers measured with a simple oral iron load test. Nephron 73: 403-406
8. Hallberg L, Brune M, Rossander L 1989 The role of vitamin C in iron absorption. Int J Vitam Nutr Res 30 (Suppl): 103-108
9. Hamstra RD, Block MH, Schocket AL 1980 Intravenous iron dextran in clinical medicine. JAMA 243: 1726-1731
10. Hayashi H, Tak T, Nishimura N, Moyoyoshi Y, Isomura T, Sakamoto N 1994 Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron. Am J Gastroenterol 89: 986-988
11. Hocken AG, Marwah PK 1971 latrogenic contribution to anemia of chronic renal failure. Lancet 4: 164-165
12. Ifudu O, Feldman J, Friedman EA 1996 The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 334: 420-425
13. Juric M, Rupcic V, Topuzovic N, Jakic M, Brlosic A, Rusic A, Karner I, Stipanic S, Kes P 1995 Haemodynamic changes and exercise tolerance in dialysis patients treated with erythropoietin. Nephrol Dial Transplant 10: 1398-1404
14. Kushner D, Beckman B, Nguyen L et al 1989 The role of polyamines and uremic serum inhibitors in the anemia of end stage renal disease (ESRD). Am Soc Nephrol 22nd Annual Meeting 52A
15. Lim VS, Flanigan MJ 1996 Erythropoietin treatment and iron supplementation. Kidney: A Current Survey Of World Literature 5: 105-107
16. Lustbader ED, Hann HW, Blumberg B 1983 Serum ferritin as a predictor of host response to hepatitis B infection. Science 220: 423-425
17. Lynch SR 1997 Interaction of iron with other nutrients. Nutr Rev 55: 102-110
18. Milman N 1982 Iron absorption measured by whole body counting and the relation to marrow iron stores in chronic uremia. Clin Nephrol 17: 77-81
19. Olynic JK, Reddy KR, Di Bisceglie et al 1995 Hepatic iron concentration as a predictor of response to interferon alfa therapy in chronic hepatitis C. Gastroenterology 108: 1104-1109
20. Patruta SI, Edlinger R, Sunder-Plassmann G, Horl WH 1998 Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency. J Am Soc Nephrol 9: 655-663
21. Radtke HW, Frei U, Erbes PM, Schoeppe W, Koch KM 1980 Improving anemia by hemodialysis. Kidney Int 17: 382-387
22. Tarng DC, Huang TP 1998 A parallel, comparative study of intravenous iron versus intravenous ascorbic acid for erythropoietin-hyporesponsive anaemia in haemodialysis patients with iron overload. Nephrol Dial Transplant 13: 2873-2876
23. Vanholder R, Ringoir S 1993 Infectious morbidity and defects phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 3: 1541-1554
24. Van Thiel DH, Friedlander L, Fagiuoli S, Wright HI, Irish W, Gavaler JS 1994 Response to interferon alfa therapy is influenced by the iron content of the liver. J Hepatol 20: 410-415
25. Wingard RL, Parker RA, Ismail N, Hakim RM 1995 Efficacy of oral iron therapy in patients receiving recombinant human erythropoietin. Am J Kidney Dis 25: 443-439